ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990